Help close loopholes in regulating compounders, Hamburg asks states

The FDA asked state officials to help close gaps in the oversight of the safety of compounded drugs following the meningitis outbreak tied to tainted drugs from the New England Compounding Center. The agency's authority should be clear when monitoring the operations of compounding pharmacies and health officials should act before problems that risk public safety arise, FDA Commissioner Dr. Margaret Hamburg said. Furthermore, Hamburg said, better training is needed for state regulators, and states and the FDA need to better share information.

View Full Article in:

Reuters · New York Times (tiered subscription model), The · Tennessean (Nashville) (tiered subscription model), The

Published in Brief: